Showing results (1-10 of 969) with videos related to
Sort By:
Pageof 97
Journal of Neuroimmunology|August 29, 2006
Antibodies as biological markers for pathophysiological processes in MSMarkus Reindl, Michael Khalil, Thomas BergerJournal of the Neurological Sciences|March 21, 2007
Multiple sclerosis: disease biomarkers as indicated by pathophysiologyThomas Berger, Markus ReindlDisease Markers|November 25, 2006
Biomarkers in multiple sclerosis: role of antibodiesThomas Berger, Markus ReindlCentral Nervous System Agents in Medicinal Chemistry|March 19, 2010
Multiple sclerosis - established and novel therapeutic approachesRainer Ehling, Thomas Berger, Markus ReindlCurrent Medicinal Chemistry|August 21, 2007
Biological markers for multiple sclerosisAndreas Lutterotti, Thomas Berger, Markus ReindlResults and Problems in Cell Differentiation|June 11, 2009
B cells and antibodies in MSMarkus Reindl, Bettina Kuenz, Thomas BergerJournal of Neuroimmunology|July 26, 2005
Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosisBettina Kuenz, Andreas Lutterotti, Michael Khalil, et al.Multiple Sclerosis and Related Disorders|March 11, 2018
New clinical implications of anti-myelin oligodendrocyte glycoprotein antibodies in children with CNS demyelinating diseasesFranziska Di Pauli, Markus Reindl, Thomas BergerJournal of Neuroimmunology|March 7, 2006
Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatmentsMichael Khalil, Markus Reindl, Andreas Lutterotti, et al.Nature Reviews. Neurology|August 15, 2022
Pathogenic autoantibodies in multiple sclerosis - from a simple idea to a complex conceptRomana Höftberger, Hans Lassmann, Thomas Berger, et al.Pageof 97